Thalassemia is an inherited (i.e., passed from parents to children through genes)?blood disorder caused when the body doesn't make enough of a protein called hemoglobin, an important part of red blood cells.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Thalassemia industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Folic Acid
Deferasirox
Deferiprone
Hydroxyurea
Market Segment by Product Application
Hospitals
Ambulatory Surgical Centers
Others
Finally, the report provides detailed profile and data information analysis of leading company.
GlaxoSmithKline
Novartis AG
Bellicum Pharmaceuticals
Acceleron Pharma
Johnson & Johnson
Merck & Co.
Gilead Sciences, Inc.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Thalassemia consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Thalassemia market by identifying its various subsegments.
3.Focuses on the key global Thalassemia manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Thalassemia with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Thalassemia submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Thalassemia Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Thalassemia Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Thalassemia Segment by Type
2.1.1 Folic Acid
2.1.2 Deferasirox
2.1.3 Deferiprone
2.1.4 Hydroxyurea
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Ambulatory Surgical Centers
2.2.3 Others
2.3 Global Thalassemia Market Comparison by Regions (2017-2027)
2.3.1 Global Thalassemia Market Size (2017-2027)
2.3.2 North America Thalassemia Status and Prospect (2017-2027)
2.3.3 Europe Thalassemia Status and Prospect (2017-2027)
2.3.4 China Thalassemia Status and Prospect (2017-2027)
2.3.5 Japan Thalassemia Status and Prospect (2017-2027)
2.3.6 Southeast Asia Thalassemia Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Thalassemia Industry Impact
2.5.1 Thalassemia Business Impact Assessment - Covid-19
2.5.2 Market Trends and Thalassemia Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Thalassemia Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Thalassemia Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Thalassemia Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Thalassemia Manufacturer Market Share
3.5 Top 10 Thalassemia Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Thalassemia Market
3.7 Key Manufacturers Thalassemia Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Thalassemia Industry Key Manufacturers
4.1 GlaxoSmithKline
4.1.1 Compan Detail
4.1.2 GlaxoSmithKline Thalassemia Product Introduction, Application and Specification
4.1.3 GlaxoSmithKline 138 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GlaxoSmithKline News
4.2 Novartis AG
4.2.1 Compan Detail
4.2.2 Novartis AG Thalassemia Product Introduction, Application and Specification
4.2.3 Novartis AG Thalassemia Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GlaxoSmithKline News
4.3 Bellicum Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Bellicum Pharmaceuticals Thalassemia Product Introduction, Application and Specification
4.3.3 Bellicum Pharmaceuticals Thalassemia Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bellicum Pharmaceuticals News
4.4 Acceleron Pharma
4.4.1 Compan Detail
4.4.2 Acceleron Pharma Thalassemia Product Introduction, Application and Specification
4.4.3 Acceleron Pharma Thalassemia Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Acceleron Pharma News
4.5 Johnson & Johnson
4.5.1 Compan Detail
4.5.2 Acceleron Pharma Thalassemia Product Introduction, Application and Specification
4.5.3 Johnson & Johnson Thalassemia Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Johnson & Johnson News
4.6 Merck & Co.
4.6.1 Compan Detail
4.6.2 Merck & Co. Thalassemia Product Introduction, Application and Specification
4.6.3 Merck & Co. Thalassemia Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Merck & Co. News
4.7 Gilead Sciences, Inc.
4.7.1 Compan Detail
4.7.2 Gilead Sciences, Inc. Thalassemia Product Introduction, Application and Specification
4.7.3 Gilead Sciences, Inc. Thalassemia Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
5 Global Thalassemia Market Segment by Big Type
5.1 Global Thalassemia Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Thalassemia Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Thalassemia Revenue and Market Share by Big Type (2017-2022)
5.2 Folic Acid Sales Growth Rate and Price
5.2.1 Global Folic Acid Sales Growth Rate (2017-2022)
5.2.2 Global Folic Acid Price (2017-2022)
5.3 Deferasirox Sales Growth Rate and Price
5.3.1 Global Deferasirox Sales Growth Rate (2017-2022)
5.3.2 Global Deferasirox Price (2017-2022)
5.4 Deferiprone Sales Growth Rate and Price
5.4.1 Global Deferiprone Sales Growth Rate (2017-2022)
5.4.2 Global Deferiprone Price (2017-2022)
5.5 Hydroxyurea Sales Growth Rate and Price
5.5.1 Global Hydroxyurea Sales Growth Rate (2017-2022)
5.5.2 Global Hydroxyurea Price (2017-2022)
6 Global Thalassemia Market Segment by Big Application
6.1 Global Thalassemia Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Ambulatory Surgical Centers Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Thalassemia Forecast
7.1 Global Thalassemia Revenue, Sales and Growth Rate (2022-2027)
7.2 Thalassemia Market Forecast by Regions (2022-2027)
7.2.1 North America Thalassemia Market Forecast (2022-2027)
7.2.2 Europe Thalassemia Market Forecast (2022-2027)
7.2.3 China Thalassemia Market Forecast (2022-2027)
7.2.4 Japan Thalassemia Market Forecast (2022-2027)
7.2.5 Southeast Asia Thalassemia Market Forecast (2022-2027)
7.2.6 Other Regions Thalassemia Market Forecast (2022-2027)
7.3 Thalassemia Market Forecast by Type (2022-2027)
7.3.1 Global Thalassemia Sales Forecast by Type (2022-2027)
7.3.2 Global Thalassemia Market Share Forecast by Type (2022-2027)
7.4 Thalassemia Market Forecast by Application (2022-2027)
7.4.1 Global Thalassemia Sales Forecast by Application (2022-2027)
7.4.2 Global Thalassemia Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Thalassemia Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Thalassemia Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Thalassemia
Figure Market Concentration Ratio and Market Maturity Analysis of Thalassemia
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Thalassemia Market Size by Big Type
Figure Global Market Share of Thalassemia by Big Type in 2021
Figure Folic Acid Picture (2017-2022)
Figure Deferasirox Picture (2017-2022)
Figure Deferiprone Picture (2017-2022)
Global Thalassemia Market Size by Big Application
Table Global Thalassemia Market Size by Application
Figure Global Thalassemia Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Thalassemia Comparison by Regions (M USD) (2017-2027)
Figure Global Thalassemia Market Size (Million US$) (2017-2027)
Figure North America Thalassemia Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Thalassemia Revenue (Million US$) Growth Rate (2017-2027)
Figure China Thalassemia Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Thalassemia Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Thalassemia Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Thalassemia Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Thalassemia Sales by Manufacturer (2017-2022)
Figure Global Thalassemia Sales Market Share by Manufacturer in 2021
Table Global Thalassemia Revenue by Manufacturer (2017-2022)
Figure Global Thalassemia Revenue Market Share by Manufacturer in 2021
Table Global Thalassemia Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Thalassemia Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Thalassemia Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Thalassemia Market
Table Key Manufacturers Thalassemia Product Type
Table Mergers & Acquisitions Planning
Table GlaxoSmithKline Company Profile
Table Thalassemia Product Introduction, Application and Specification of GlaxoSmithKline
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Novartis AG Company Profile
Table Thalassemia Product Introduction, Application and Specification of Novartis AG
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Recent Development
Table Bellicum Pharmaceuticals Company Profile
Table Thalassemia Product Introduction, Application and Specification of Bellicum Pharmaceuticals
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bellicum Pharmaceuticals Main Business
Table Bellicum Pharmaceuticals Recent Development
Table Acceleron Pharma Company Profile
Table Thalassemia Product Introduction, Application and Specification of Acceleron Pharma
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Acceleron Pharma Main Business
Table Acceleron Pharma Recent Development
Table Acceleron Pharma Main Business
Table Acceleron Pharma Recent Development
Table Johnson & Johnson Company Profile
Table Thalassemia Product Introduction, Application and Specification of Johnson & Johnson
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Merck & Co. Company Profile
Table Thalassemia Product Introduction, Application and Specification of Merck & Co.
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Main Business
Table Merck & Co. Recent Development
Table Gilead Sciences, Inc. Company Profile
Table Thalassemia Product Introduction, Application and Specification of Gilead Sciences, Inc.
Table Thalassemia Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gilead Sciences, Inc. Main Business
Table Gilead Sciences, Inc. Recent Development
Figure Global Thalassemia Sales and Growth Rate (2017-2022)
Figure Global Thalassemia Revenue and Growth Rate (2017-2022)
Table Global Thalassemia Sales by Regions (2017-2022)
Figure Global Thalassemia Sales Market Share by Regions in 2021
Table Global Thalassemia Revenue by Regions (2017-2022)
Figure Global Thalassemia Revenue Market Share by Regions in 2021
Figure North America Thalassemia Sales and Growth Rate (2017-2022)
Figure Europe Thalassemia Sales and Growth Rate (2017-2022)
Figure China Thalassemia Sales and Growth Rate (2017-2022)
Figure Japan Thalassemia Sales and Growth Rate (2017-2022)
Figure Southeast Asia Thalassemia Sales and Growth Rate (2017-2022)
Figure Other Regions Thalassemia Sales and Growth Rate (2017-2022)
Table Global Thalassemia Sales by Big Type (2017-2022)
Table Global Thalassemia Sales Market Share by Big Type (2017-2022)
Figure Global Thalassemia Sales Market Share by Big Type in 2019
Table Global Thalassemia Revenue by Big Type (2017-2022)
Table Global Thalassemia Revenue Market Share by Big Type (2017-2022)
Table Global Thalassemia Revenue Market Share by Big Type in 2019
Figure Global Folic Acid Sales Growth Rate (2017-2022)
Figure Global Folic Acid Price (2017-2022)
Figure Global Deferasirox Sales Growth Rate (2017-2022)
Figure Global Deferasirox Price (2017-2022)
Figure Global Deferiprone Sales Growth Rate (2017-2022)
Figure Global Deferiprone Price (2017-2022)
Figure Global Hydroxyurea Sales Growth Rate (2017-2022)
Table Global Thalassemia Sales by Big Application (2017-2022)
Table Global Thalassemia Sales Market Share by Big Application (2017-2022)
Figure Global Thalassemia Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Ambulatory Surgical Centers Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Thalassemia Sales and Growth Rate (2022-2027)
Figure Global Thalassemia Revenue and Growth Rate (2022-2027)
Table Global Thalassemia Sales Forecast by Regions (2022-2027)
Table Global Thalassemia Market Share Forecast by Regions (2022-2027)
Figure North America Sales Thalassemia Market Forecast (2022-2027)
Figure Europe Sales Thalassemia Market Forecast (2022-2027)
Figure China Sales Thalassemia Market Forecast (2022-2027)
Figure Japan Sales Thalassemia Market Forecast (2022-2027)
Figure Southeast Asia Sales Thalassemia Market Forecast (2022-2027)
Figure Other Regions Sales Thalassemia Market Forecast (2022-2027)
Table Global Thalassemia Sales Forecast by Type (2022-2027)
Table Global Thalassemia Market Share Forecast by Type (2022-2027)
Table Global Thalassemia Sales Forecast by Application (2022-2027)
Table Global Thalassemia Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalassemia
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Thalassemia Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Thalassemia Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Thalassemia Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Thalassemia Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Thalassemia Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Thalassemia Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Thalassemia Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Thalassemia Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)